GSK logo

GSK plc (GSK) Selling, General & Administrative Expenses

Annual SG&A:

$253.01M+$5.64M(+2.28%)
December 31, 2024

Summary

  • As of today, GSK annual SG&A is $253.01 million, with the most recent change of +$5.64 million (+2.28%) on December 31, 2024.
  • During the last 3 years, GSK annual SG&A has risen by +$20.58 million (+8.85%).
  • GSK annual SG&A is now -98.74% below its all-time high of $20.15 billion, reached on December 31, 2010.

Performance

1-Year Change

+2.28%

3-Year Change

+8.85%

5-Year Change

-49.54%

15-Year Change

-97.97%

GSK SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

90.82%
GSK annual SG&A is higher than 90.82% of companies in Healthcare sector

Range

All-Time High

$20.15B
GSK annual SG&A is currently -98.74% below its historical high of $20.15 billion

3-Year Low

$232.43M
GSK annual SG&A is currently +8.85% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
GSK previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
GSK next annual earnings announcement has not yet been scheduled

OtherGSKincome statement metrics

Annual Total Expenses

$34.96B
GSK annual total expenses is $34.96 billion

Annual Operating Expenses

$23.40B
GSK annual total operating expenses is $23.40 billion

Annual Cost Of Goods Sold

$12.11B
GSK annual cost of goods sold is $12.11 billion

Annual Interest Expense

$0.00
GSK annual interest expense is $0.00

Quarterly SG&A:

$2.86B+$251.66M(+9.65%)
June 30, 2025

Summary

  • As of today, GSK quarterly SG&A is $2.86 billion, with the most recent change of +$251.66 million (+9.65%) on June 30, 2025.
  • Over the past year, GSK quarterly SG&A has dropped by -$251.73 million (-8.09%).
  • GSK quarterly SG&A is now -59.29% below its all-time high of $7.02 billion, reached on December 31, 2010.

Performance

3-Month Change

+9.65%

1-Year Change

-8.09%

3-Year Change

+10.3%

5-Year Change

-15%

GSK Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

99.38%
GSK quarterly SG&A is higher than 99.38% of companies in Healthcare sector

Range

All-Time High

$7.02B
GSK quarterly SG&A is currently -59.29% below its historical high of $7.02 billion

3-Year Low

$2.42B
GSK quarterly SG&A is currently +18.26% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
GSK previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Oct 29, 2025
GSK next earnings announcement is scheduled for Oct 29, 2025

OtherGSKincome statement metrics

Quarterly Total Expenses

$8.74B
GSK quarterly total expenses is $8.74 billion

Quarterly Operating Expenses

$5.49B
GSK quarterly total operating expenses is $5.49 billion

Quarterly Cost Of Goods Sold

$2.89B
GSK quarterly cost of goods sold is $2.89 billion

Quarterly Interest Expense

$0.00
GSK quarterly interest expense is $0.00

TTM SG&A:

$43.52B+$1.21B(+2.85%)
June 30, 2025

Summary

  • As of today, GSK TTM SG&A is $43.52 billion, with the most recent change of +$1.21 billion (+2.85%) on June 30, 2025.
  • Over the past year, GSK TTM SG&A has increased by +$31.54 billion (+263.17%).
  • GSK TTM SG&A is now -27.93% below its all-time high of $60.39 billion.

Performance

3-Month Change

+209.33%

1-Year Change

+263.17%

3-Year Change

+322.94%

5-Year Change

+190.82%

GSK TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

97.63%
GSK TTM SG&A is higher than 97.63% of companies in Healthcare sector

Range

All-Time High

$60.39B
GSK TTM SG&A is currently -27.93% below its historical high of $60.39 billion

3-Year Low

$25.52B
GSK TTM SG&A is currently +70.56% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
GSK previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Oct 29, 2025
GSK next earnings announcement is scheduled for Oct 29, 2025

OtherGSKincome statement metrics

Annual Total Expenses

$34.96B
GSK annual total expenses is $34.96 billion

Annual Operating Expenses

$23.40B
GSK annual total operating expenses is $23.40 billion

TTM Cost Of Goods Sold

$11.60B
GSK TTM cost of goods sold is $11.60 billion

TTM Interest Expense

$0.00
GSK TTM interest expense is $0.00

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SG&A

$253.01M
GSK annual SG&A is $253.01 million

Annual Operating Expenses

$23.40B
GSK annual total operating expenses is $23.40 billion

Annual Cost Of Goods Sold

$12.11B
GSK annual cost of goods sold is $12.11 billion

GSK Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+2.3%-8.1%+263.2%
3Y3 Years+8.8%+10.3%+322.9%
5Y5 Years-49.5%-15.0%+190.8%

GSK Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+8.8%-42.1%+18.3%at high+70.6%
5Y5-Year-51.6%+8.8%-42.1%+23.6%at high+70.6%
All-TimeAll-Time-98.7%>+9999.0%-59.3%>+9999.0%-27.9%+245.3%

GSK Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$2.86B(+9.7%)
$13.82B(-1.8%)
Mar 2025
-
$2.61B(-23.6%)
$14.07B(-0.3%)
Dec 2024
$253.01M(+2.3%)
$3.41B(-30.9%)
$14.11B(+0.6%)
Sep 2024
-
$4.94B(+58.8%)
$14.02B(+17.0%)
Jun 2024
-
$3.11B(+17.5%)
$11.98B(+2.3%)
Mar 2024
-
$2.65B(-20.4%)
$11.71B(+0.4%)
Dec 2023
$247.37M(+4.6%)
$3.32B(+14.3%)
$11.67B(+4.1%)
Sep 2023
-
$2.91B(+2.3%)
$11.21B(+4.6%)
Jun 2023
-
$2.84B(+9.0%)
$10.72B(+2.4%)
Mar 2023
-
$2.60B(-8.9%)
$10.47B(+1.7%)
Dec 2022
$236.50M(+1.8%)
$2.86B(+18.3%)
$10.30B(-0.9%)
Sep 2022
-
$2.42B(-6.7%)
$10.39B(+1.0%)
Jun 2022
-
$2.59B(+6.6%)
$10.29B(+2.3%)
Mar 2022
-
$2.43B(-17.8%)
$10.06B(-8.4%)
Dec 2021
$232.43M(-55.6%)
$2.96B(+27.8%)
$10.98B(-10.0%)
Sep 2021
-
$2.31B(-2.1%)
$12.20B(-8.5%)
Jun 2021
-
$2.36B(-29.4%)
$13.33B(-7.0%)
Mar 2021
-
$3.35B(-19.8%)
$14.33B(-2.6%)
Dec 2020
$523.20M(+4.4%)
$4.18B(+21.1%)
$14.71B(-1.7%)
Sep 2020
-
$3.45B(+2.5%)
$14.97B(-0.8%)
Jun 2020
-
$3.36B(-9.7%)
$15.08B(+0.2%)
Mar 2020
-
$3.73B(-15.9%)
$15.05B(+3.4%)
Dec 2019
$501.37M(-96.2%)
$4.43B(+24.3%)
$14.55B(+7.9%)
Sep 2019
-
$3.56B(+7.1%)
$13.49B(+2.1%)
Jun 2019
-
$3.33B(+3.2%)
$13.22B(-0.1%)
Mar 2019
-
$3.23B(-4.3%)
$13.23B(+0.1%)
Dec 2018
$13.22B(+6.1%)
$3.37B(+2.3%)
$13.22B(+0.1%)
Sep 2018
-
$3.29B(-1.4%)
$13.21B(+2.1%)
Jun 2018
-
$3.34B(+3.9%)
$12.94B(+2.3%)
Mar 2018
-
$3.22B(-4.3%)
$12.64B(+1.4%)
Dec 2017
$12.46B(-1.2%)
$3.36B(+11.3%)
$12.46B(+0.1%)
Sep 2017
-
$3.02B(-0.9%)
$12.45B(+0.1%)
Jun 2017
-
$3.05B(+0.2%)
$12.44B(-0.3%)
Mar 2017
-
$3.04B(-9.3%)
$12.48B(-0.5%)
Dec 2016
$12.60B(-10.6%)
$3.35B(+11.4%)
$12.54B(-3.4%)
Sep 2016
-
$3.01B(-2.5%)
$12.98B(-0.1%)
Jun 2016
-
$3.09B(-0.5%)
$13.00B(-6.1%)
Mar 2016
-
$3.10B(-18.2%)
$13.84B(-1.8%)
Dec 2015
$14.10B(+3.9%)
$3.79B(+25.2%)
$14.10B(+2.1%)
Sep 2015
-
$3.03B(-22.9%)
$13.81B(-2.2%)
Jun 2015
-
$3.93B(+16.8%)
$14.12B(+3.3%)
Mar 2015
-
$3.36B(-3.8%)
$13.67B(+0.6%)
Dec 2014
$13.58B(+10.5%)
$3.49B(+4.8%)
$13.58B(+7.4%)
Sep 2014
-
$3.33B(-4.1%)
$12.64B(+2.1%)
Jun 2014
-
$3.48B(+6.1%)
$12.38B(+0.6%)
Mar 2014
-
$3.28B(+28.2%)
$12.31B(+0.4%)
Dec 2013
$12.29B(-11.5%)
$2.55B(-16.9%)
$12.26B(-7.3%)
Sep 2013
-
$3.07B(-9.6%)
$13.23B(-3.3%)
Jun 2013
-
$3.40B(+5.5%)
$13.68B(-0.6%)
Mar 2013
-
$3.23B(-8.4%)
$13.76B(-1.0%)
Dec 2012
$13.88B(+4.3%)
$3.52B(-0.2%)
$13.90B(+5.8%)
Sep 2012
-
$3.53B(+1.5%)
$13.13B(+2.3%)
Jun 2012
-
$3.48B(+3.4%)
$12.84B(-2.6%)
Mar 2012
-
$3.37B(+22.1%)
$13.18B(-0.7%)
Dec 2011
$13.32B(-33.9%)
$2.76B(-14.9%)
$13.27B(-24.3%)
Sep 2011
-
$3.24B(-15.3%)
$17.54B(+0.3%)
Jun 2011
-
$3.82B(+10.6%)
$17.48B(-12.3%)
Mar 2011
-
$3.46B(-50.8%)
$19.93B(-0.9%)
Dec 2010
$20.15B
$7.02B(+120.7%)
$20.11B(+12.2%)
DateAnnualQuarterlyTTM
Sep 2010
-
$3.18B(-49.3%)
$17.92B(-1.9%)
Jun 2010
-
$6.27B(+72.6%)
$18.26B(+18.3%)
Mar 2010
-
$3.64B(-24.7%)
$15.44B(+3.2%)
Dec 2009
$15.05B(+6.8%)
$4.83B(+37.2%)
$14.96B(+9.7%)
Sep 2009
-
$3.52B(+1.9%)
$13.64B(+1.0%)
Jun 2009
-
$3.45B(+9.5%)
$13.51B(-0.8%)
Mar 2009
-
$3.15B(-10.2%)
$13.61B(-2.3%)
Dec 2008
$14.09B(+1.3%)
$3.51B(+3.6%)
$13.93B(+0.5%)
Sep 2008
-
$3.39B(-4.8%)
$13.86B(+0.9%)
Jun 2008
-
$3.56B(+2.6%)
$13.74B(-0.7%)
Mar 2008
-
$3.47B(+0.7%)
$13.84B(+1.5%)
Dec 2007
$13.92B(+4.2%)
$3.45B(+5.5%)
$13.64B(+33.8%)
Sep 2007
-
$3.27B(-10.6%)
$10.19B(+47.2%)
Jun 2007
-
$3.66B(+11.9%)
$6.93B(+111.9%)
Mar 2007
-
$3.27B(>+9900.0%)
$3.27B(>+9900.0%)
Dec 2006
$13.36B(+1.4%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2006
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2006
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2006
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2005
$13.17B(-0.1%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2005
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2005
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2005
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2004
$13.19B(+6.5%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2004
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2004
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2004
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2003
$12.38B(>+9900.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2003
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2003
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2003
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2002
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2002
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2002
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2002
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2001
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2001
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 2001
-
$0.00(0.0%)
$2.56B(-52.0%)
Mar 2001
-
$0.00(-100.0%)
$5.33B(-32.0%)
Dec 2000
$0.00(0.0%)
-
-
Sep 2000
-
$2.56B(-7.7%)
$7.83B(+48.5%)
Jun 2000
-
$2.77B(+10.6%)
$5.27B(+44.1%)
Mar 2000
-
$2.50B(+117.0%)
$3.66B(+217.0%)
Dec 1999
$0.00(-100.0%)
-
-
Jun 1999
-
$1.15B(+5.2%)
$1.15B(+5.2%)
Dec 1998
$4.45B(+3.2%)
-
-
Jun 1998
-
$1.10B
$1.10B
Dec 1997
$4.32B(+5.0%)
-
-
Dec 1996
$4.11B(-1.8%)
-
-
Dec 1995
$4.19B(+40.7%)
-
-
Jun 1994
$2.98B(>+9900.0%)
-
-
Jun 1993
$0.00(0.0%)
-
-
Jun 1992
$0.00(0.0%)
-
-
Jun 1991
$0.00(-100.0%)
-
-
Jun 1990
$63.47M(+42.2%)
-
-
Jun 1989
$44.62M(+154.5%)
-
-
Jun 1988
$17.54M(+91.6%)
-
-
Jun 1987
$9.15M(+27.1%)
-
-
Jun 1986
$7.20M
-
-

FAQ

  • What is GSK plc annual SG&A?
  • What is the all-time high annual SG&A for GSK plc?
  • What is GSK plc annual SG&A year-on-year change?
  • What is GSK plc quarterly SG&A?
  • What is the all-time high quarterly SG&A for GSK plc?
  • What is GSK plc quarterly SG&A year-on-year change?
  • What is GSK plc TTM SG&A?
  • What is the all-time high TTM SG&A for GSK plc?
  • What is GSK plc TTM SG&A year-on-year change?

What is GSK plc annual SG&A?

The current annual SG&A of GSK is $253.01M

What is the all-time high annual SG&A for GSK plc?

GSK plc all-time high annual SG&A is $20.15B

What is GSK plc annual SG&A year-on-year change?

Over the past year, GSK annual SG&A has changed by +$5.64M (+2.28%)

What is GSK plc quarterly SG&A?

The current quarterly SG&A of GSK is $2.86B

What is the all-time high quarterly SG&A for GSK plc?

GSK plc all-time high quarterly SG&A is $7.02B

What is GSK plc quarterly SG&A year-on-year change?

Over the past year, GSK quarterly SG&A has changed by -$251.73M (-8.09%)

What is GSK plc TTM SG&A?

The current TTM SG&A of GSK is $43.52B

What is the all-time high TTM SG&A for GSK plc?

GSK plc all-time high TTM SG&A is $60.39B

What is GSK plc TTM SG&A year-on-year change?

Over the past year, GSK TTM SG&A has changed by +$31.54B (+263.17%)
On this page